Literature DB >> 12105153

Allopurinol and endothelial function in heart failure: future or fantasy?

Ulf Landmesser, Helmut Drexler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12105153     DOI： 10.1161/01.cir.0000024270.37833.f9

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

2.  Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.

Authors:  A D Gavin; A D Struthers
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

3.  Clinical risk factors demonstrate an age-dependent relationship with oxidative stress biomarkers in African Americans.

Authors:  Kathleen M Sturgeon; Deborah L Feairheller; Keith M Diaz; Sheara T Williamson; Praveen Veerabhadrappa; Michael D Brown
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

4.  Effects of allopurinol on cardiac function and oxidant stress in chronic intermittent hypoxia.

Authors:  Antoinette L Williams; Ling Chen; Steven M Scharf
Journal:  Sleep Breath       Date:  2009-07-15       Impact factor: 2.816

5.  Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.

Authors:  J E Macdonald; N Kennedy; A D Struthers
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

6.  Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD.

Authors:  Mingyao Sun; Nicole Hines; Diego Scerbo; Jane Buchanan; Chaorong Wu; Patrick Ten Eyck; Diana Zepeda-Orozco; Eric B Taylor; Diana I Jalal
Journal:  Antioxidants (Basel)       Date:  2022-06-29

7.  Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.

Authors:  Jon White; Reecha Sofat; Gibran Hemani; Tina Shah; Jorgen Engmann; Caroline Dale; Sonia Shah; Felix A Kruger; Claudia Giambartolomei; Daniel I Swerdlow; Tom Palmer; Stela McLachlan; Claudia Langenberg; Delilah Zabaneh; Ruth Lovering; Alana Cavadino; Barbara Jefferis; Chris Finan; Andrew Wong; Antoinette Amuzu; Ken Ong; Tom R Gaunt; Helen Warren; Teri-Louise Davies; Fotios Drenos; Jackie Cooper; Shah Ebrahim; Debbie A Lawlor; Philippa J Talmud; Steve E Humphries; Christine Power; Elina Hypponen; Marcus Richards; Rebecca Hardy; Diana Kuh; Nicholas Wareham; Yoav Ben-Shlomo; Ian N Day; Peter Whincup; Richard Morris; Mark W J Strachan; Jacqueline Price; Meena Kumari; Mika Kivimaki; Vincent Plagnol; John C Whittaker; George Davey Smith; Frank Dudbridge; Juan P Casas; Michael V Holmes; Aroon D Hingorani
Journal:  Lancet Diabetes Endocrinol       Date:  2016-01-16       Impact factor: 44.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.